- Home
- ASTH vs NEO Comparison
ASTH vs NEO Comparison
Compare ASTH & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTH | NEO |
|---|---|---|
| Founded | 1994 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ASTH | NEO |
|---|---|---|
| Price | $33.92 | $19.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $34.86 | $13.38 |
| AVG Volume (30 Days) | 287.8K | ★ 1.6M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $27.38 | $10.63 |
| Revenue Next Year | $10.78 | $9.73 |
| P/E Ratio | $49.49 | ★ N/A |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $7.07 |
| 52 Week High | $51.60 | $19.89 |
Technical Indicators
Market Signals| Indicator | ASTH | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 31.55 | 71.65 |
| Support Level | $20.57 | $16.87 |
| Resistance Level | $40.11 | $19.76 |
| Average True Range (ATR) | 1.74 | 0.79 |
| MACD | -0.39 | 0.14 |
| Stochastic Oscillator | 8.37 | 90.35 |
Price Performance
Historical ComparisonAbout ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.